Related Experiment Video
Updated: Jul 20, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Physicians underdiagnose and undertreat obesity in ishemic heart disease patients: data from the HOLEM Study Group
Eyal Leibovitz1, Yariv Gerber, Maximo Maislos
1Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel Hashomer, Israel.
Insights
Physicians rarely documented obesity or recommended weight loss for ischemic heart disease patients. This oversight in medical records highlights a gap in addressing obesity as a critical cardiovascular disease risk factor.
Area of Science:
- Cardiology
- Public Health
- Medical Informatics
Background:
- Obesity is a significant, independent risk factor for ischemic heart disease (IHD).
- Obesity negatively impacts other cardiovascular disease risk factors.
- Effective management of IHD requires addressing all contributing risk factors, including obesity.
Purpose of the Study:
- To assess physician awareness and documentation of obesity in patients with IHD.
- To examine how obesity is recorded in hospital discharge letters for IHD patients.
- To evaluate the frequency of weight loss recommendations for obese IHD patients.
Main Methods:
- Analysis of the HOLEM database, focusing on discharge letters from 2994 IHD patients.
- Data collected from four Israeli hospitals between 1998-2000.
- Review included documentation of risk factors, treatment, and verification of diagnosis and risk status post-discharge.
Main Results:
- 32% of IHD patients were obese (BMI ≥ 30 kg/m²).
- Obesity was noted in discharge letters for only 39.6% of obese and 65.8% of morbidly obese patients.
- Weight loss was recommended in just 15% of obese patients' discharge letters; notation correlated with BMI and number of risk factors.
Conclusions:
- Most obese IHD patients' discharge letters failed to document weight status.
- Weight loss recommendations were infrequently provided to obese IHD patients.
- There is a significant gap in addressing obesity management within IHD patient discharge summaries.
Background:
Obesity is an independent risk factor for ischemic heart disease and affects the status of other risk factors for cardiovascular disease.
Objective:
To study the attitude of physicians to obesity by examining discharge letters of overweight patients with ischemic heart disease.
Methods:
We used the HOLEM database for this analysis. The HOLEM project was designed to study the NCEP (National Cholesterol Education Program) guideline implementation among patients with IHD at hospital discharge. We documented the recording of risk factors and treatment recommendations for IHD by reviewing the discharge letters of 2994 IHD patients admitted to four central hospitals in Israel between 1998 and 2000. A follow-up visit was held 6-8 weeks after discharge, at which time the diagnosis of IHD was verified, risk factor status was checked, height and weight were measured and drug treatment was reviewed.
Results:
Mean body mass index was 28.3 kg/m2 and 32% were obese (BMI > or = 30 kg/m2). Only 39.6% of the obese patients and 65.8% of the morbidly obese patients (BMI > or = 40 kg/m2) had "obesity" noted in their discharge letters, and weight loss recommendation was written in only 15% of the obese patients' discharge letters. Acute episodes like acute myocardial infarction and unstable angina did not influence the notation of obesity, and only BMI and the number of additional risk factors were positively correlated with the notation of this risk factor.
Conclusions:
Despite the importance of obesity, weight status was not noted and weight loss was not recommended in most of the discharge letters of obese IHD patients.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Drug Dosing: Obese Patients
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Atherosclerosis III: Management
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Coronary Artery Disease I: Introduction
